During a Senate HELP Committee hearing, Robert F. Kennedy Jr. stated that President Trump is dedicated to bringing drug ...

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

Based on recent policy signals and statements from incoming administration officials, a picture of potential regulatory and policy changes that ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

$510,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Implementation of the Inflation ...

The BIOSECURE Act was passed with a large bipartisan majority in the House in 2024 and now awaits action in the Senate in 2025. Passage of the Act would be a significant first step in protecting ...

As Donald Trump prepares to assume the presidency on January 20, 2025, the healthcare industry faces a period of potential upheaval. From rising tariffs to drug pricing reforms, the administration’s ...

Billions hang in the balance as Trump's pro-business reputation could clash with congressional efforts to pass the Biosecure Act, according to Jefferies analysts. The legislation would prevent any ...

The 264-159 vote to pass the Laken Riley Act puts pressure on Senate Democrats to support the legislation when Republicans, who now control the upper chamber, bring it to the floor for an initial ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the Ohio-based regulatory consulting firm NAMSA. | The deal includes facilities in ...